Stock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO

Stock Track2025-10-08

PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the company's initial public offering (IPO) announcement, which has garnered substantial investor interest.

According to the company's statement, PomDoctor has priced its IPO at $4.00 per American Depositary Share (ADS). The offering consists of 5,000,004 ADSs, which is expected to raise approximately $20 million in gross proceeds. This successful pricing and the subsequent listing on a major U.S. exchange appear to be driving the stock's impressive performance in its first day of trading.

The IPO also includes an option for underwriters to purchase up to an additional 750,000 ADSs, potentially increasing the total capital raised. With its shares now trading under the ticker symbol "POM", PomDoctor's strong market debut suggests positive investor sentiment towards the company's future prospects. As the trading session progresses, market participants will be closely watching to see if the stock can maintain its early momentum.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1159154155?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-08 23:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1159154155","market":"sg","top_or_hot":-1,"title":"Stock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO","media":"Stock Track","content":"<p>PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the company's initial public offering (IPO) announcement, which has garnered substantial investor interest.</p>\n\n<p>According to the company's statement, PomDoctor has priced its IPO at $4.00 per American Depositary Share (ADS). The offering consists of 5,000,004 ADSs, which is expected to raise approximately $20 million in gross proceeds. This successful pricing and the subsequent listing on a major U.S. exchange appear to be driving the stock's impressive performance in its first day of trading.</p>\n\n<p>The IPO also includes an option for underwriters to purchase up to an additional 750,000 ADSs, potentially increasing the total capital raised. With its shares now trading under the ticker symbol \"POM\", PomDoctor's strong market debut suggests positive investor sentiment towards the company's future prospects. As the trading session progresses, market participants will be closely watching to see if the stock can maintain its early momentum.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | PomDoctor Soars 12.50% in Intraday Trading Following Nasdaq IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-08 23:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the company's initial public offering (IPO) announcement, which has garnered substantial investor interest.</p>\n\n<p>According to the company's statement, PomDoctor has priced its IPO at $4.00 per American Depositary Share (ADS). The offering consists of 5,000,004 ADSs, which is expected to raise approximately $20 million in gross proceeds. This successful pricing and the subsequent listing on a major U.S. exchange appear to be driving the stock's impressive performance in its first day of trading.</p>\n\n<p>The IPO also includes an option for underwriters to purchase up to an additional 750,000 ADSs, potentially increasing the total capital raised. With its shares now trading under the ticker symbol \"POM\", PomDoctor's strong market debut suggests positive investor sentiment towards the company's future prospects. As the trading session progresses, market participants will be closely watching to see if the stock can maintain its early momentum.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"POM","symbol_name":"石榴云医","start_time":0,"source_url":"","article_id":"1159154155","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1159154155","pubTimestamp":1759937781,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"POM":"石榴云医"},"translate_title":"个股轨迹|纳斯达克IPO后PomDoctor盘中大涨12.50%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"POM":1},"content_text":"PomDoctor (NASDAQ: POM) saw its stock price surge 12.50% in intraday trading on Wednesday, as the company made its debut on the Nasdaq stock exchange. The significant uptick comes on the heels of the company's initial public offering (IPO) announcement, which has garnered substantial investor interest.\nAccording to the company's statement, PomDoctor has priced its IPO at $4.00 per American Depositary Share (ADS). The offering consists of 5,000,004 ADSs, which is expected to raise approximately $20 million in gross proceeds. This successful pricing and the subsequent listing on a major U.S. exchange appear to be driving the stock's impressive performance in its first day of trading.\nThe IPO also includes an option for underwriters to purchase up to an additional 750,000 ADSs, potentially increasing the total capital raised. With its shares now trading under the ticker symbol \"POM\", PomDoctor's strong market debut suggests positive investor sentiment towards the company's future prospects. As the trading session progresses, market participants will be closely watching to see if the stock can maintain its early momentum.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1159154155","isCrawlerRequest":true}